Jordan Continues To Develop As A Drug Manufacturing Base

According to recently released data, the Jordanian drug industry exported products worth JOD198.6mn (US$280mn) in 2005, which is directly in line with BMI estimates. However, BMI believes that the Jordanian government's forecast that the sector will more than triple by 2010 to reach US$1bn is overly optimistic. BMI expects the market to reach only US$450mn by 2010, due to strong global price pressure on generic medicines. Adnan Badwan, the general director of local drugmaker JPM reflects this view, claiming that the government prediction is not 'feasible' primarily owing to a lack of capital investment in the

To read the full article, please choose one of the following options: